Revenue: The sum of all revenue fields included for a company's operating activities.
CytoDyn Inc. (CYDY) Revenue data is not available for the most recently reported fiscal quarter, ending 2026-02-28.
| Income Statement Financials | |
|
Revenue |
-- |
$-5.05M |
|
-- |
|
-- |
|
$6.30M |
|
$-6.30M |
|
$1.61M |
|
$-4.69M |
|
$-4.69M |
|
$-4.69M |
|
$-4.69M |
|
$-4.69M |
|
$-4.69M |
|
$-6.30M |
|
$-6.30M |
|
1.28B |
|
1.28B |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$18.44M |
|
-- |
|
$0.06M |
|
$18.50M |
|
$50.43M |
|
$27.20M |
|
$72.36M |
|
$122.78M |
|
$-104.29M |
|
$-104.29M |
|
$-104.29M |
|
1.36B |
|
| Cash Flow Statement Financials | |
$-12.32M |
|
-- |
|
$16.07M |
|
$11.90M |
|
$15.65M |
|
$3.75M |
|
$0.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.37 |
|
-- |
|
-- |
|
-0.35 |
|
-0.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
4.50% |
|
4.50% |
|
-25.36% |
|
6.08% |
|
$-0.08 |
|
$-0.01 |
|
$-0.01 |
|